Dr. Eric Schuur is a seasoned life science executive with over 25 years of experience driving innovation within early-stage companies. Trained at UCLA and Scripps Research Institute, he has a proven track record of building and scaling successful biotech ventures. His expertise spans regenerative medicine, gene therapy, diagnostics, and oncology. Dr. Schuur's leadership has been instrumental in bringing groundbreaking therapies and diagnostic tools to market, including a pivotal role in developing one of the first oncolytic viruses and leading a clinical team to FDA approval for an asthma treatment. He is currently focused on revolutionizing liver disease treatment at Hepatx. Beyond his entrepreneurial pursuits, Dr. Schuur is actively involved in mentoring and shaping the future of life sciences through his roles in academic and industry advisory boards.